NCT01619033View on ClinicalTrials.gov

Pharmacokinetics of BF2.649 in Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Renal Impairment

Interventions

DRUG

BF2.649

single dose 20 mg

Trial Locations (1)

Unknown

EUROFINS OPTIMED Lyon, Lyon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bioprojet

OTHER